Rocket Lab Just Hit 93 Electron Launches. Is the Neutron Timeline Still the Stock's Biggest Risk?

Rocket Lab reiterated that its Electron rocket is reliable with the 93rd launch, but investor focus remains on Neutron’s development delays—now projected for a first flight in 2027 (pushed from 2024 and repeatedly delayed). Management is pushing commercialization via acquisitions (Mynaric, Optical Support, Iridium Communications) and a planned paying Neutron customer (Kepler Communications), yet the stock has continued to fall from its late-May peak. The article flags the key debate: Neutron timeline risk versus analyst claims the shares are worth ~$116 (+70% vs the current price), implying near-term upside is capped by execution uncertainty.

Analysis

The key mechanism is not launch reliability; it is duration risk. Electron proves the base business is real, but it also caps the addressable market, so RKLB still trades like a binary option on Neutron execution. Every quarter of delay gives incumbents and adjacent suppliers a chance to lock in multi-year contracts, which is why the stock can underreact to operational wins and overreact to schedule slips.

In the next 1-3 months, the stock is likely to remain headline-driven because there is no independently verifiable revenue bridge large enough to offset Neutron slippage. The main bear case is a creeping fixed-cost problem: if development burns cash while the launch date moves out, margin leverage worsens before any medium-lift revenue arrives. That matters more than the current Electron cadence because the market is paying for future mix, not present throughput.

Contrarian view: the downside may be less than the market fears if investors finally start valuing RKLB as a diversified space systems company rather than a pure launch story. That said, the re-rating case needs proof—paid customer conversions, launch milestones, and evidence that acquisitions are accretive to cash generation rather than a distraction. If Neutron slips again, the 6-18 month multiple could compress materially; if it hits a hard date, the stock can re-rate fast on incremental credibility rather than on earnings.

Key Decisions for Investors

• Avoid adding fresh long exposure to RKLB until management publishes a hard Neutron test/launch milestone that can be independently checked; the risk/reward is poor while the timeline remains elastic.
• Tactically short RKLB on any relief rally over the next 2-6 weeks, with the thesis invalidated by a firm first-flight date or a material backlog/customer announcement tied to Neutron.
• For defined risk, consider 3-6 month RKLB put spreads instead of outright short stock; this expresses schedule-risk downside while capping losses if the market keeps rewarding space sentiment.
• Set a catalyst alert for the next 1-2 quarters: if Neutron slips again or cash burn widens without offsetting product/service growth, use that as the point to press the bearish view.
• If you want to own the optionality, wait for a post-milestone pullback and only buy after the first successful flight or a visibly de-risked launch cadence; before that, you are paying equity value for unproven execution.